Annual report pursuant to Section 13 and 15(d)

Document and Entity Information

v3.19.3.a.u2
Document and Entity Information - USD ($)
$ in Millions
 12 Months Ended
Sep. 30, 2019
Jan. 07, 2020
Mar. 31, 2019
Cover [Abstract]      
Entity Registrant Name NeuBase Therapeutics, Inc.    
Entity Central Index Key 0001173281    
Document Type 10-K    
Entity File Number 333-88480    
Entity Incorporation, State Code DE    
Document Period End Date Sep. 30, 2019    
Amendment Flag false    
Current Fiscal Year End Date --09-30    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity's Reporting Status Current Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Common Stock, Shares Outstanding   17,077,873  
Entity Public Float     $ 5.8
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2019